INS and Hypoglycemia: Due to the fact that long-acting insulin has a stable hypoglycemic effect, small inter-individual and intra-individual differences, high reproducibility in the daytime, and a low risk of nocturnal hypoglycemia, researchers are committed to the research and development of new long-acting insulin biosimilars (Tibaldi, 2014).